EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neck management in cT1 ‐ 2N0 oral squamous cell carcinoma: Act or watchful wait?

Zi-Zhan Li iD, Li-Ya Wei, Lei-Ming Cao, Guang-Rui Wang, Kan Zhou, Yao Xiao, Han-Yue Luo, Si-Jie Zhang, Qiuji Wu iD, Bing Liu, Lin-Lin Bu iD

International Journal of Cancer · 15.08.2025 · 157 (4) · 614-626

DOI: 10.1002/ijc.35455 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 23.04.2025. Verfasst von Zi-Zhan Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Watchful Waiting, Neck Dissection, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, Hubei Province Chinese Medicine Research, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The controversy over neck management for cT1‐2N0 OSCC patients has persisted for two decades. While selective neck dissection (SND) has been deemed effective, only 30% of patients actually exhibit lymph node metastasis (LNM). SND‐related complications, such as shoulder dysfunction and lymphedema, significantly impact patient quality of life, suggesting that 70% of patients may not benefit from SND. Current guidelines advocate observation, sentinel lymph node biopsy (SLNB), and SND, but the appropriate scenarios for each strategy need further exploration. Risk stratification assessment can inform treatment decisions in early‐stage OSCC. This review explores histological risk factors, SLNB, gene expression profiles, and biomarkers for risk stratification. Additionally, we assess the potential value of postoperative radiotherapy (PORT) and immunotherapy, particularly immune checkpoint blockade (ICB), in cT1‐2N0 OSCC. Risk‐stratified approaches align with personalized medicine and precision surgery trends, while PORT and ICB may offer more reliable neck management options. This comprehensive review systematically synthesizes the past selection of therapeutic strategies for cT1‐2N0 OSCC patients, alongside their respective strengths and limitations. We aspire to contribute to the optimization of treatment strategies for early‐stage OSCC patients, ultimately enhancing both survival outcomes and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsWatchful WaitingNeck DissectionSquamous Cell Carcinoma of Head and NeckHumansSentinel Lymph Node BiopsyNeoplasm StagingQuality of LifeLymphatic Metastasis

Stichwörter der Autor:innen

cT1‐2N0 OSCCearly OSCClymph node metastasisneck dissectionsentinel lymph node biopsy

Autor:innen und Institutionen

  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…
  • Department of Oral & Maxillofacial - Head Neck Oncology, School & Hospital of Stomatology, Wuhan University, Wuhan, China.
  • Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.

ORCID-Profile: Zi-Zhan Li, Qiuji Wu, Lin-Lin Bu

Förderung

  • Natural Science Foundation of Hubei Province
  • Hubei Province Chinese Medicine Research
  • Fundamental Research Funds for the Central Universities
  • Health Commission of Hubei Province Scientific Research
  • Leading Discipline of Oncology Construction Project of Zhongnan Hospital of Wuhan University
  • Youth Interdisciplinary Special Fund of Zhongnan Hospital of Wuhan University
  • Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University
  • Knowledge Innovation Program of Wuhan-Shuguang

Zitieren

APA

Li, Z. Z., Wei, L. Y., Cao, L. M., Wang, G. R., Zhou, K., Xiao, Y., Luo, H. Y., Zhang, S. J., Wu, Q., Liu, B., & Bu, L. L. (2025). Neck management in cT1 ‐ 2N0 oral squamous cell carcinoma: Act or watchful wait?. International Journal of Cancer, 157(4), 614-626. https://doi.org/10.1002/ijc.35455

Vancouver

Li ZZ, Wei LY, Cao LM, Wang GR, Zhou K, Xiao Y, et al. Neck management in cT1 ‐ 2N0 oral squamous cell carcinoma: Act or watchful wait?. International Journal of Cancer. 2025;157(4):614-626. doi:10.1002/ijc.35455

BibTeX
@article{Li2025,
  author = {Li, Zi-Zhan and Wei, Li-Ya and Cao, Lei-Ming and Wang, Guang-Rui and Zhou, Kan and Xiao, Yao and Luo, Han-Yue and Zhang, Si-Jie and Wu, Qiuji and Liu, Bing and Bu, Lin-Lin},
  title = {Neck management in cT1 ‐ 2N0 oral squamous cell carcinoma: Act or watchful wait?},
  journal = {International Journal of Cancer},
  year = {2025},
  volume = {157},
  number = {4},
  pages = {614--626},
  doi = {10.1002/ijc.35455}
}
Kostenlos starten →